COPENHAGEN – A certain online Seattle retailer unexpectedly featured during a BIO-Europe panel discussion Tuesday on transformative deals in the pharma industry. In among the anecdotes and insights about the deals that enabled certain well-known drug assets to get to market – and that may in the future enable certain lesser known assets to follow – Amazon.com's entry into pharmaceutical distribution through its acquisition of the Boston-based online pharmacy Pillpack Inc. sparked some uneasy reflection.